Literature DB >> 33308298

CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression.

Yanan Zhang1, Lu Zhao1, Shizhou Yang2, Yixuan Cen1, Tingjia Zhu1, Lingfang Wang1, Lili Xia1, Yuwan Liu1, Jian Zou2, Junfen Xu2, Yang Li2, Xiaodong Cheng2, Weiguo Lu2, Xinyu Wang3, Xing Xie4.   

Abstract

BACKGROUND: Circular RNAs (circRNAs) have been reported to play key roles in the development of various cancers. However, the biological functions and clinical significance of most circRNAs are still elusive. The purpose of this study was to explore the function and mechanism of a certain circRNA named circCDKN2B-AS1 in cervical cancer development and its potential value in the clinic.
METHODS: qRT-PCR was used to verify the expression level of circCDKN2B-AS1. CCK-8, Transwell, and flow cytometry (FCM) assays were performed to detect cellular proliferation, migration, and apoptosis, respectively. A Seahorse XFe96 Analyzer was used to measure glycolysis metabolism level. RNA pull-down, RNA immunoprecipitation (RIP), actinomycin-D addition assays and Western blotting were used to screen and elucidate the potential mechanisms involved. BALB/c nude mice and zebrafish embryos (AB, WT) were used as animal models to investigate tumorigenesis capability. 18FDG-microPET/CT imaging and lactic acid (LA) and pyruvic acid (PA) content detection assays were used to detect the level of glucose metabolism in subcutaneous tumors from nude mice.
RESULTS: CircCDKN2B-AS1, a circular isoform of the long noncoding RNA (lncRNA) CDKN2B-AS1, was upregulated in cervical cancer and precancerous tissues. We found that circCDKN2B-AS1 associated with the IMP3 protein depending on a specific binding site and regulated the stability of Hexokinase 2 (HK2) mRNA, the rate-limiting enzyme of the aerobic glycolysis pathway. The expression level of circCDKN2B-AS1 fated the binding of IMP3 to the 3' untranslated region (UTR) of HK2 mRNA, consequently affecting the malignant cell phenotype and aerobic glycolysis in cervical cancer in vitro and in vivo. Mutant circCDKN2B-AS1, lacking the IMP3 binding site, did not have such effects. Utilization of an inhibitory peptide to block the interaction between circCDKN2B-AS1 and the IMP3 protein impeded the binding of IMP3 to the 3'UTR of HK2 mRNA and suppressed aerobic glycolysis in cervical cancer cells.
CONCLUSIONS: Our findings demonstrate that circCDKN2B-AS1 facilitates aerobic glycolysis by sponging the IMP3 protein to stabilize HK2 mRNA, consequently promoting the malignant phenotype in cervical cancer, which may provide a potential approach for cervical cancer therapeutics.

Entities:  

Keywords:  Aerobic glycolysis; Cervical cancer; CircCDKN2B-AS1; CircRNA; HK2; IMP3

Year:  2020        PMID: 33308298     DOI: 10.1186/s13046-020-01793-7

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  38 in total

Review 1.  The biogenesis, biology and characterization of circular RNAs.

Authors:  Lasse S Kristensen; Maria S Andersen; Lotte V W Stagsted; Karoline K Ebbesen; Thomas B Hansen; Jørgen Kjems
Journal:  Nat Rev Genet       Date:  2019-08-08       Impact factor: 53.242

2.  Cervical cancer prevention in China: a key to cancer control.

Authors:  Fanghui Zhao; Youlin Qiao
Journal:  Lancet       Date:  2019-03-09       Impact factor: 79.321

3.  The biogenesis and emerging roles of circular RNAs.

Authors:  Ling-Ling Chen
Journal:  Nat Rev Mol Cell Biol       Date:  2016-02-24       Impact factor: 94.444

Review 4.  Cervical cancer.

Authors:  Paul A Cohen; Anjua Jhingran; Ana Oaknin; Lynette Denny
Journal:  Lancet       Date:  2019-01-12       Impact factor: 79.321

Review 5.  Cervical cancer: A global health crisis.

Authors:  William Small; Monica A Bacon; Amishi Bajaj; Linus T Chuang; Brandon J Fisher; Matthew M Harkenrider; Anuja Jhingran; Henry C Kitchener; Linda R Mileshkin; Akila N Viswanathan; David K Gaffney
Journal:  Cancer       Date:  2017-05-02       Impact factor: 6.860

6.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

7.  Improved survival with bevacizumab in advanced cervical cancer.

Authors:  Krishnansu S Tewari; Michael W Sill; Harry J Long; Richard T Penson; Helen Huang; Lois M Ramondetta; Lisa M Landrum; Ana Oaknin; Thomas J Reid; Mario M Leitao; Helen E Michael; Bradley J Monk
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

8.  Natural RNA circles function as efficient microRNA sponges.

Authors:  Thomas B Hansen; Trine I Jensen; Bettina H Clausen; Jesper B Bramsen; Bente Finsen; Christian K Damgaard; Jørgen Kjems
Journal:  Nature       Date:  2013-02-27       Impact factor: 49.962

Review 9.  Function and clinical significance of circRNAs in solid tumors.

Authors:  Yiting Geng; Jingting Jiang; Changping Wu
Journal:  J Hematol Oncol       Date:  2018-07-31       Impact factor: 17.388

10.  Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?

Authors:  Karin Sundström; K Miriam Elfström
Journal:  PLoS Med       Date:  2020-01-28       Impact factor: 11.069

View more
  15 in total

1.  Oncogenic circTICRR suppresses autophagy via binding to HuR protein and stabilizing GLUD1 mRNA in cervical cancer.

Authors:  Tingjia Zhu; Yixuan Cen; Zhuoye Chen; Yanan Zhang; Lu Zhao; Jiaying Wang; Weiguo Lu; Xing Xie; Xinyu Wang
Journal:  Cell Death Dis       Date:  2022-05-20       Impact factor: 9.685

Review 2.  CircRNAs and their regulatory roles in cancers.

Authors:  Mei Tao; Ming Zheng; Yanhua Xu; Shuo Ma; Weiwei Zhang; Shaoqing Ju
Journal:  Mol Med       Date:  2021-08-26       Impact factor: 6.354

3.  hsa_circ_0119412 overexpression promotes cervical cancer progression by targeting miR-217 to upregulate anterior gradient 2.

Authors:  Yumei Lv; Mingyi Wang; Mingli Chen; Dan Wang; Mingyan Luo; Qingyuan Zeng
Journal:  J Clin Lab Anal       Date:  2022-03-11       Impact factor: 2.352

4.  CircRNA circ_0023984 promotes the progression of esophageal squamous cell carcinoma via regulating miR-134-5p/cystatin-s axis.

Authors:  Ge Yang; Yu Zhang; Hongni Lin; Jinnbo Liu; Shengjie Huang; Wei Zhong; Chao Peng; Lin Du
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

5.  Mechanisms of action of triptolide against colorectal cancer: insights from proteomic and phosphoproteomic analyses.

Authors:  Xinqiang Song; Huanhuan He; Yu Zhang; Jinke Fan; Lei Wang
Journal:  Aging (Albany NY)       Date:  2022-04-02       Impact factor: 5.682

Review 6.  Investigating the Underlying Mechanisms of Circular RNAs and Their Application in Clinical Research of Cervical Cancer.

Authors:  Jian Liu; He Zhu; Li Fu; Tianmin Xu
Journal:  Front Genet       Date:  2021-03-25       Impact factor: 4.599

Review 7.  Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer.

Authors:  Miaomiao Huo; Jingyao Zhang; Wei Huang; Yan Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-24

8.  hsa_circ_0005358 suppresses cervical cancer metastasis by interacting with PTBP1 protein to destabilize CDCP1 mRNA.

Authors:  Yixuan Cen; Tingjia Zhu; Yanan Zhang; Lu Zhao; Jiawei Zhu; Lingfang Wang; Junfen Xu; Tian Ding; Xing Xie; Xinyu Wang; Weiguo Lu
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-29       Impact factor: 8.886

9.  The Correlation of HK2 Gene Expression with the Occurrence, Immune Cell Infiltration, and Prognosis of Renal Cell Carcinoma.

Authors:  Chunhui Liu; Huibing Li; Hua Huang; Pengyi Zheng; Zhijun Li
Journal:  Dis Markers       Date:  2022-02-27       Impact factor: 3.434

10.  Circular RNA hsa_circ_0000511 Improves Epithelial Mesenchymal Transition of Cervical Cancer by Regulating hsa-mir-296-5p/HMGA1.

Authors:  Jia Xie; Qian Chen; Ping Zhou; Wenli Fan
Journal:  J Immunol Res       Date:  2021-05-27       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.